True Irradiance/Dosing Guide

Red light therapy has emerged from experimental treatment to well-researched medicine, with hundreds of peer-reviewed studies demonstrating therapeutic benefits across many conditions. This guide synthesizes the latest research to help you understand how to use red light therapy effectively, but remember—this is a starting point, not a rigid prescription.

Individual responses vary significantly based on skin type, age, genetics, and health status. Think of these protocols as educated starting points for your own exploration. What works optimally for one person may need adjustment for another, and that's completely normal in photobiomodulation therapy.

The key principle underlying effective red light therapy is the biphasic dose-response relationship: too little light provides no benefit, optimal amounts produce therapeutic effects, but too much can actually inhibit healing. This means finding your personal "sweet spot" through careful observation and gradual adjustment.

Important Disclaimer: Individual Variation is the Rule, Not the Exception

Your skin type significantly affects treatment response. Fair skin absorbs light differently than darker skin tones, with melanin content influencing both penetration depth and heat generation. Fitzpatrick skin types I-III typically tolerate standard protocols well, while types IV-VI may need longer treatment times at greater distances or reduced frequencies to achieve similar benefits.

Age influences treatment response through changes in skin thickness, circulation, and cellular energy production. Younger individuals often respond more quickly to standard protocols, while older adults may benefit from gentler approaches with longer treatment periods.

Health status and medications can affect photosensitivity and healing responses. If you're taking photosensitizing medications or have underlying health conditions, start with very conservative protocols and consult healthcare providers when appropriate.

This guide provides evidence-based starting points—expect to adjust based on your individual response. Pay attention to how your body responds and modify timing, distance, and frequency accordingly. For specific dosing recommendations, refer to the comprehensive treatment tables that follow this guide.

How Red Light Therapy Works: The Science Made Simple

Your cells have tiny powerhouses called mitochondria that produce the energy your body needs to heal and function. Red and near-infrared light, when delivered at the right wavelengths (630-850nm), can boost these cellular power plants to work more efficiently.

Dr. Michael Hamblin's research has shown that specific wavelengths of light activate an enzyme called cytochrome c oxidase in your mitochondria. When this happens, your cells produce more ATP (cellular energy), reduce inflammation, and accelerate healing processes. It's like giving your cells a gentle energy boost to help them work better.

The "biphasic response" is crucial to understand: a little light may do nothing, the right amount provides benefits, but too much can actually be counterproductive. This is why finding your personal optimal dose is more important than following any rigid protocol.

Different wavelengths penetrate to different depths: red light (630-670nm) works well for skin and surface tissues, while near-infrared light (810-850nm) penetrates deeper to reach muscles, joints, and other tissues. SECOTRA devices combine multiple wavelengths to provide comprehensive coverage for various applications.

Understanding Wavelength Selection

Recent wavelength optimization studies have refined understanding of tissue-specific responses to different portions of the red and near-infrared spectrum. The most comprehensive research focuses on six primary wavelengths: 630nm, 660nm, 670nm, 810nm, 830nm, and 850nm, each with distinct penetration characteristics and cellular targets.

Red wavelengths (630-670nm) demonstrate superior effectiveness for superficial tissue applications, with 660nm emerging as the most studied wavelength in dermatological and surface healing applications. These wavelengths penetrate approximately 5mm into tissue, making them ideal for skin conditions, wound healing, and surface muscle treatment.

Near-infrared wavelengths (810-850nm) provide deeper tissue penetration, reaching 10-30mm depth depending on tissue composition and skin type. Literature reviews consistently identify 810-830nm as superior to 850nm for most clinical applications. The 830nm wavelength has demonstrated maximum tissue penetration while maintaining optimal absorption by cytochrome c oxidase, making it the preferred choice for joint therapy, deep muscle treatment, and brain applications.

Multi-wavelength combinations consistently outperform single wavelengths in clinical studies. Different wavelengths target different tissue depths and may activate complementary cellular pathways, which is why SECOTRA devices include the full spectrum of therapeutic wavelengths.

Understanding Skin Type and Individual Factors

Skin penetration physics fundamentally determines effective treatment protocols, with wavelength-specific penetration depths varying significantly based on tissue optical properties. Fair skin (Fitzpatrick Types I-III) allows effective penetration across the full therapeutic spectrum, while darker skin (Fitzpatrick Types IV-VI) requires wavelengths >750nm for optimal penetration due to increased melanin absorption.

Fitzpatrick Skin Type Classifications:

  • Type I: Very fair, always burns, never tans
  • Type II: Fair, usually burns, tans minimally
  • Type III: Medium, sometimes burns, tans gradually
  • Type IV: Olive, rarely burns, tans easily
  • Type V: Brown, very rarely burns, tans very easily
  • Type VI: Black, never burns, tans very easily

Fitzpatrick skin type adjustments are critical for safe and effective treatment, with darker skin types requiring adjusted protocols and experiencing more heating at higher intensities. Types IV-VI benefit from wavelength selection >750nm, extended treatment intervals, and careful monitoring to prevent thermal effects while maintaining therapeutic benefits.

Age-related factors significantly impact treatment response through structural and cellular changes. Collagen degradation, dermal thinning, and vascular changes in aging skin alter light scattering patterns and cellular responsiveness. Younger patients typically respond to standard protocols, while older adults may benefit from extended treatment protocols with adjusted parameters.

General Treatment Principles

Start Conservative: Begin with the lower end of recommended treatment ranges and gradually increase based on your individual response. The detailed dosing tables provide specific time and distance recommendations for your skin type and condition.

Consistency Over Intensity: Regular, moderate treatments typically produce better results than occasional high-intensity sessions. Most research suggests 3-5 times per week for active treatment phases, reducing to maintenance frequencies once you achieve desired results.

Distance Flexibility: SECOTRA devices provide therapeutic benefits at various distances. Closer distances deliver higher intensity for targeted treatments, while farther distances provide gentler, broader coverage. The treatment tables show how to achieve optimal doses at different distances.

Listen to Your Body: You should feel little to no warming during treatment. If the skin feels hot or uncomfortable, increase distance or reduce treatment time. The therapeutic effects come from the light itself, not from heating.

Treatment Applications Overview

Pain Management: Research demonstrates significant pain reduction across acute and chronic conditions. The mechanism involves reducing inflammation, improving circulation, and modulating pain signaling. Treatment parameters vary by condition severity and tissue depth.

Skin Health and Anti-Aging: Clinical trials show 25-35% increases in collagen density with proper protocols. Optimal results combine red wavelengths for collagen stimulation with near-infrared for deeper tissue remodeling.

Athletic Performance and Recovery: Studies show enhanced muscle performance when applied before exercise and faster recovery when used post-workout. The key is targeting the appropriate muscle groups with adequate energy delivery.

Hair Growth: FDA-cleared protocols demonstrate 35-51% increases in hair count for androgenic alopecia. Success requires specific wavelengths (655nm ± 20nm), consistent application, and patience—results typically appear after 4-6 months.

Neurological Applications: Emerging research shows potential for cognitive enhancement, depression support, and neuroprotection. These applications require specific protocols targeting brain tissue through the skull.

Safety and Common Sense Guidelines

Red light therapy is generally very safe when used responsibly, but paying attention to your body's responses is always important.

Eye Protection: Essential when treating face, head, or neck areas. Never look directly into the LEDs. Simple laser safety glasses or just closing your eyes and facing away from the panel works fine.

Photosensitivity Considerations: Start conservatively if you have sensitive skin or take medications that increase photosensitivity. Some medications can make skin more reactive to light therapy.

Skin Type Guidelines:

  • Fair skin (Types I-III): Generally tolerates standard protocols well
  • Darker skin (Types IV-VI): May need longer treatment times or greater distances to achieve similar benefits without excessive heating

When to Avoid Treatment: Skip treatments if you have active skin infections, open wounds (unless specifically treating them), or during acute illness. Pregnant women should avoid abdominal treatments as a precaution.

Progressive Approach: Most conditions benefit from a progressive treatment schedule:

  • Phase 1 (Weeks 1-2): Lower doses, assess tolerance
  • Phase 2 (Weeks 3-8): Optimal therapeutic doses
  • Phase 3 (Ongoing): Maintenance protocols

Using This Guide with the Dosing Tables

This guide provides the scientific foundation and general principles for photobiomodulation therapy. For specific treatment recommendations including:

  • Exact treatment times for your device and distance
  • Condition-specific protocols
  • Skin type adjustments
  • Progressive treatment schedules

Refer to the comprehensive dosing tables that follow this guide. These tables translate the research into practical protocols specifically calibrated for SECOTRA devices, accounting for individual factors like skin type and treatment goals.

Remember, these protocols represent starting points based on current research. Your individual response may require adjustments to timing, frequency, or distance. Keep notes on your treatments and responses to help optimize your personal protocol over time.

Conclusion

Photobiomodulation therapy represents a remarkable convergence of physics, biology, and medicine. When applied with proper understanding of the underlying principles and individual factors, red light therapy can provide significant therapeutic benefits across a wide range of conditions.

The key to success lies in understanding the biphasic dose-response relationship, selecting appropriate wavelengths for target tissues, and applying consistent protocols that respect individual factors like skin type, age, and condition severity. By combining the scientific principles outlined in this guide with the specific protocols in the dosing tables, you can optimize your photobiomodulation therapy for safe and effective results.

Always remember that this technology works best as part of a comprehensive approach to health and wellness. While red light therapy can provide significant benefits, it works synergistically with proper nutrition, adequate sleep, regular exercise, and appropriate medical care when needed.

SECOTRA Photobiomodulation Therapy Dosing Tables

Evidence-Based Treatment Protocols with 40% Tissue Penetration Factor

IMPORTANT MEDICAL DISCLAIMER:

This guide is for educational purposes only and does not constitute medical advice. These protocols are adaptations of published research studies modified for SECOTRA device specifications. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before beginning any light therapy program, especially if you have a medical condition or are taking medications. Individual results may vary significantly.

Key Information:

  • All calculations account for ~40% tissue penetration (60% loss due to reflection/absorption)
  • Times are rounded to nearest 15-30 seconds for practical application
  • Start with lower doses and gradually increase based on individual response
  • Simple 1EQ Full Spectrum: 145 mW/cm² (6"), 122 mW/cm² (12"), 73 mW/cm² (24"), 47 mW/cm² (36")
  • Simple 2EQ Full Spectrum: 155 mW/cm² (6"), 125 mW/cm² (12"), 90 mW/cm² (24"), 61 mW/cm² (36")
  • NIR-Only Mode (60% power): Multiply full spectrum irradiance by 0.6

Wavelength Recommendations by Condition:

  • Surface/Skin: 630-670nm (red) primary, 810-850nm (NIR) secondary
  • Deep Tissue/Muscle: 810-850nm (NIR) primary, 630-670nm (red) secondary
  • Joint/Bone: 830-850nm (NIR) optimal for penetration
  • Brain/Neurological: 810nm optimal transcranial penetration
  • Wound Healing: 660nm + 830nm combination ideal
  • Hair Growth: 655nm ± 20nm optimal per FDA studies

PAIN MANAGEMENT PROTOCOLS

Recommended Wavelengths: 660nm + 830-850nm combination for optimal results

Acute Pain (Target: 2.5-10 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
6"Simple 1EQ Full6-25 J/cm²2.4-10 J/cm²45 sec - 3 minDaily × 3-5 days
6"Simple 2EQ Full6-25 J/cm²2.4-10 J/cm²40 sec - 2.5 minDaily × 3-5 days
12"Simple 1EQ Full6-25 J/cm²2.4-10 J/cm²50 sec - 3.5 minDaily × 3-5 days
12"Simple 2EQ Full6-25 J/cm²2.4-10 J/cm²50 sec - 3.5 minDaily × 3-5 days
18"Simple 1EQ Full6-25 J/cm²2.4-10 J/cm²1 - 5 minDaily × 3-5 days
18"Simple 2EQ Full6-25 J/cm²2.4-10 J/cm²1 - 4.5 minDaily × 3-5 days
24"Simple 1EQ Full6-25 J/cm²2.4-10 J/cm²1.5 - 6 minDaily × 3-5 days
24"Simple 2EQ Full6-25 J/cm²2.4-10 J/cm²1 - 5 minDaily × 3-5 days
36"Simple 1EQ Full6-25 J/cm²2.4-10 J/cm²2 - 9 minDaily × 3-5 days
36"Simple 2EQ Full6-25 J/cm²2.4-10 J/cm²1.5 - 7 minDaily × 3-5 days

Chronic Pain (Target: 4-20 J/cm² tissue dose)

Recommended Wavelengths: 810-850nm primary for deep penetration

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
6"Simple 1EQ Full10-50 J/cm²4-20 J/cm²1 - 6 min3×/week
6"Simple 2EQ Full10-50 J/cm²4-20 J/cm²1 - 5.5 min3×/week
12"Simple 1EQ Full10-50 J/cm²4-20 J/cm²1.5 - 7 min3×/week
12"Simple 2EQ Full10-50 J/cm²4-20 J/cm²1.5 - 7 min3×/week
18"Simple 1EQ Full10-50 J/cm²4-20 J/cm²2 - 10 min3×/week
18"Simple 2EQ Full10-50 J/cm²4-20 J/cm²1.5 - 8.5 min3×/week
24"Simple 1EQ Full10-50 J/cm²4-20 J/cm²2.5 - 11.5 min3×/week
24"Simple 2EQ Full10-50 J/cm²4-20 J/cm²2 - 9 min3×/week
36"Simple 1EQ Full10-50 J/cm²4-20 J/cm²3.5 - 18 min3×/week
36"Simple 2EQ Full10-50 J/cm²4-20 J/cm²3 - 14 min3×/week

Arthritis (Target: 4-8 J/cm² tissue dose)

Recommended Wavelengths: 830nm optimal for joint penetration

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
6"Simple 1EQ Full10-20 J/cm²4-8 J/cm²1 - 2.5 minDaily or EOD
6"Simple 2EQ Full10-20 J/cm²4-8 J/cm²1 - 2 minDaily or EOD
12"Simple 1EQ Full10-20 J/cm²4-8 J/cm²1.5 - 3 minDaily or EOD
12"Simple 2EQ Full10-20 J/cm²4-8 J/cm²1.5 - 2.5 minDaily or EOD
18"Simple 1EQ Full10-20 J/cm²4-8 J/cm²2 - 4 minDaily or EOD
18"Simple 2EQ Full10-20 J/cm²4-8 J/cm²1.5 - 3.5 minDaily or EOD
24"Simple 1EQ Full10-20 J/cm²4-8 J/cm²2.5 - 4.5 minDaily or EOD
24"Simple 2EQ Full10-20 J/cm²4-8 J/cm²2 - 3.5 minDaily or EOD
36"Simple 1EQ Full10-20 J/cm²4-8 J/cm²3.5 - 7 minDaily or EOD
36"Simple 2EQ Full10-20 J/cm²4-8 J/cm²3 - 5.5 minDaily or EOD

Fibromyalgia - Whole Body (Target: 25-50 J/cm² tissue dose)

Recommended Wavelengths: Full spectrum for systemic effects

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
18"Simple 1EQ Full62-125 J/cm²25-50 J/cm²12 - 24 min3×/week
18"Simple 2EQ Full62-125 J/cm²25-50 J/cm²10 - 20 min3×/week
24"Simple 1EQ Full62-125 J/cm²25-50 J/cm²14 - 29 min3×/week
24"Simple 2EQ Full62-125 J/cm²25-50 J/cm²11.5 - 23 min3×/week
36"Simple 1EQ Full62-125 J/cm²25-50 J/cm²22 - 44 min3×/week
36"Simple 2EQ Full62-125 J/cm²25-50 J/cm²17 - 34 min3×/week

SKIN & AESTHETICS PROTOCOLS

Recommended Wavelengths: 630-670nm for collagen, 810-850nm for deeper remodeling

Anti-Aging/Collagen Production (Target: 3-15 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
12"Simple 1EQ Full7.5-37 J/cm²3-15 J/cm²1 - 5 min3-5×/week
12"Simple 2EQ Full7.5-37 J/cm²3-15 J/cm²1 - 5 min3-5×/week
18"Simple 1EQ Full7.5-37 J/cm²3-15 J/cm²1.5 - 7.5 min3-5×/week
18"Simple 2EQ Full7.5-37 J/cm²3-15 J/cm²1.5 - 6.5 min3-5×/week
24"Simple 1EQ Full7.5-37 J/cm²3-15 J/cm²1.5 - 8.5 min3-5×/week
24"Simple 2EQ Full7.5-37 J/cm²3-15 J/cm²1.5 - 7 min3-5×/week
36"Simple 1EQ Full7.5-37 J/cm²3-15 J/cm²2.5 - 13 min3-5×/week
36"Simple 2EQ Full7.5-37 J/cm²3-15 J/cm²2 - 10 min3-5×/week

Wound Healing (Target: 2-8 J/cm² tissue dose)

Recommended Wavelengths: 660nm + 830nm combination optimal

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
6"Simple 1EQ Full5-20 J/cm²2-8 J/cm²35 sec - 2.5 minDaily/EOD
6"Simple 2EQ Full5-20 J/cm²2-8 J/cm²30 sec - 2 minDaily/EOD
12"Simple 1EQ Full5-20 J/cm²2-8 J/cm²40 sec - 3 minDaily/EOD
12"Simple 2EQ Full5-20 J/cm²2-8 J/cm²40 sec - 2.5 minDaily/EOD
18"Simple 1EQ Full5-20 J/cm²2-8 J/cm²1 - 4 minDaily/EOD
18"Simple 2EQ Full5-20 J/cm²2-8 J/cm²45 sec - 3.5 minDaily/EOD
24"Simple 1EQ Full5-20 J/cm²2-8 J/cm²1 - 4.5 minDaily/EOD
24"Simple 2EQ Full5-20 J/cm²2-8 J/cm²1 - 3.5 minDaily/EOD

Psoriasis/Eczema (Target: 15-30 J/cm² tissue dose)

Recommended Wavelengths: 630-670nm primary, can combine with blue light

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
12"Simple 1EQ Full37-75 J/cm²15-30 J/cm²5 - 10 min3×/week
12"Simple 2EQ Full37-75 J/cm²15-30 J/cm²5 - 10 min3×/week
18"Simple 1EQ Full37-75 J/cm²15-30 J/cm²7.5 - 15 min3×/week
18"Simple 2EQ Full37-75 J/cm²15-30 J/cm²6.5 - 12.5 min3×/week
24"Simple 1EQ Full37-75 J/cm²15-30 J/cm²8.5 - 17 min3×/week
24"Simple 2EQ Full37-75 J/cm²15-30 J/cm²7 - 14 min3×/week
36"Simple 1EQ Full37-75 J/cm²15-30 J/cm²13 - 27 min3×/week
36"Simple 2EQ Full37-75 J/cm²15-30 J/cm²10 - 20 min3×/week

HAIR GROWTH PROTOCOLS

Recommended Wavelengths: 655nm ± 20nm per FDA clearances

Androgenic Alopecia (Target: 4 J/cm² tissue dose, EOD for 16-26 weeks)

DistanceDevice ModeSurface DoseTissue DoseTime per SessionFrequency
6"Simple 1EQ Full10 J/cm²4 J/cm²1 minEvery other day
6"Simple 2EQ Full10 J/cm²4 J/cm²1 minEvery other day
12"Simple 1EQ Full10 J/cm²4 J/cm²1.5 minEvery other day
12"Simple 2EQ Full10 J/cm²4 J/cm²1.5 minEvery other day
18"Simple 1EQ Full10 J/cm²4 J/cm²2 minEvery other day
18"Simple 2EQ Full10 J/cm²4 J/cm²1.5 minEvery other day
24"Simple 1EQ Full10 J/cm²4 J/cm²3 minEvery other day
24"Simple 2EQ Full10 J/cm²4 J/cm²2.5 minEvery other day
36"Simple 1EQ Full10 J/cm²4 J/cm²4.5 minEvery other day
36"Simple 2EQ Full10 J/cm²4 J/cm²4 minEvery other day

ATHLETIC PERFORMANCE & RECOVERY

Recommended Wavelengths: 830-850nm for muscle penetration

Pre-Exercise Enhancement (Target: 8-30 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeTiming
6"Simple 1EQ Full20-75 J/cm²8-30 J/cm²2.5 - 8.5 min15-30 min pre
6"Simple 2EQ Full20-75 J/cm²8-30 J/cm²2 - 8 min15-30 min pre
12"Simple 1EQ Full20-75 J/cm²8-30 J/cm²3 - 10 min15-30 min pre
12"Simple 2EQ Full20-75 J/cm²8-30 J/cm²2.5 - 10 min15-30 min pre
18"Simple 1EQ Full20-75 J/cm²8-30 J/cm²4 - 15 min15-30 min pre
18"Simple 2EQ Full20-75 J/cm²8-30 J/cm²3.5 - 12.5 min15-30 min pre
24"Simple 1EQ Full20-75 J/cm²8-30 J/cm²4.5 - 17 min15-30 min pre
24"Simple 2EQ Full20-75 J/cm²8-30 J/cm²3.5 - 14 min15-30 min pre

Post-Exercise Recovery (Target: 10-50 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeTiming
12"Simple 1EQ Full25-125 J/cm²10-50 J/cm²3.5 - 17 min<2 hrs post
12"Simple 2EQ Full25-125 J/cm²10-50 J/cm²3.5 - 17 min<2 hrs post
18"Simple 1EQ Full25-125 J/cm²10-50 J/cm²5 - 24 min<2 hrs post
18"Simple 2EQ Full25-125 J/cm²10-50 J/cm²4 - 20 min<2 hrs post
24"Simple 1EQ Full25-125 J/cm²10-50 J/cm²6 - 29 min<2 hrs post
24"Simple 2EQ Full25-125 J/cm²10-50 J/cm²5 - 23 min<2 hrs post
36"Simple 1EQ Full25-125 J/cm²10-50 J/cm²9 - 44 min<2 hrs post
36"Simple 2EQ Full25-125 J/cm²10-50 J/cm²7 - 34 min<2 hrs post

NEUROLOGICAL & COGNITIVE PROTOCOLS

Recommended Wavelengths: 810nm optimal for brain penetration

Cognitive Enhancement/Depression (Target: 10-30 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
12"Simple 1EQ Full25-75 J/cm²10-30 J/cm²3.5 - 10 min1-2×/week
12"Simple 2EQ Full25-75 J/cm²10-30 J/cm²3.5 - 10 min1-2×/week
18"Simple 1EQ Full25-75 J/cm²10-30 J/cm²5 - 15 min1-2×/week
18"Simple 2EQ Full25-75 J/cm²10-30 J/cm²4 - 12.5 min1-2×/week
24"Simple 1EQ Full25-75 J/cm²10-30 J/cm²6 - 17 min1-2×/week
24"Simple 2EQ Full25-75 J/cm²10-30 J/cm²5 - 14 min1-2×/week
36"Simple 1EQ Full25-75 J/cm²10-30 J/cm²9 - 27 min1-2×/week
36"Simple 2EQ Full25-75 J/cm²10-30 J/cm²7 - 20 min1-2×/week

Neuropathy (Target: 15-30 J/cm² tissue dose)

Recommended Wavelengths: 810-830nm for nerve penetration

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
12"Simple 1EQ Full37-75 J/cm²15-30 J/cm²5 - 10 min3×/week
12"Simple 2EQ Full37-75 J/cm²15-30 J/cm²5 - 10 min3×/week
18"Simple 1EQ Full37-75 J/cm²15-30 J/cm²7.5 - 15 min3×/week
18"Simple 2EQ Full37-75 J/cm²15-30 J/cm²6.5 - 12.5 min3×/week
24"Simple 1EQ Full37-75 J/cm²15-30 J/cm²8.5 - 17 min3×/week
24"Simple 2EQ Full37-75 J/cm²15-30 J/cm²7 - 14 min3×/week
36"Simple 1EQ Full37-75 J/cm²15-30 J/cm²13 - 27 min3×/week
36"Simple 2EQ Full37-75 J/cm²15-30 J/cm²10 - 20 min3×/week

SLEEP & CIRCADIAN RHYTHM

Recommended Wavelengths: 660-670nm red (no blue light before bed)

Sleep Enhancement (Target: 10-30 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeTiming
24"Simple 1EQ Full25-75 J/cm²10-30 J/cm²6 - 17 min1-2 hrs before bed
24"Simple 2EQ Full25-75 J/cm²10-30 J/cm²5 - 14 min1-2 hrs before bed
36"Simple 1EQ Full25-75 J/cm²10-30 J/cm²9 - 27 min1-2 hrs before bed
36"Simple 2EQ Full25-75 J/cm²10-30 J/cm²7 - 20 min1-2 hrs before bed

NIR-ONLY MODE TABLES (60% Power Output)

For deep tissue applications where red wavelengths aren't needed

NIR-Only Irradiance Values:

  • Simple 1EQ NIR: 87 mW/cm² (6"), 73 mW/cm² (12"), 44 mW/cm² (24"), 28 mW/cm² (36")
  • Simple 2EQ NIR: 93 mW/cm² (6"), 75 mW/cm² (12"), 54 mW/cm² (24"), 37 mW/cm² (36")

Deep Tissue Pain (NIR-Only, Target: 10-20 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
6"Simple 1EQ NIR25-50 J/cm²10-20 J/cm²5 - 10 min3×/week
6"Simple 2EQ NIR25-50 J/cm²10-20 J/cm²4.5 - 9 min3×/week
12"Simple 1EQ NIR25-50 J/cm²10-20 J/cm²6 - 11.5 min3×/week
12"Simple 2EQ NIR25-50 J/cm²10-20 J/cm²5.5 - 11 min3×/week
18"Simple 1EQ NIR25-50 J/cm²10-20 J/cm²8 - 16 min3×/week
18"Simple 2EQ NIR25-50 J/cm²10-20 J/cm²7 - 14 min3×/week
24"Simple 1EQ NIR25-50 J/cm²10-20 J/cm²9.5 - 19 min3×/week
24"Simple 2EQ NIR25-50 J/cm²10-20 J/cm²8 - 15.5 min3×/week
36"Simple 1EQ NIR25-50 J/cm²10-20 J/cm²15 - 30 min3×/week
36"Simple 2EQ NIR25-50 J/cm²10-20 J/cm²11 - 22.5 min3×/week

Joint/Bone Treatment (NIR-Only, Target: 8-12 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
6"Simple 1EQ NIR20-30 J/cm²8-12 J/cm²4 - 6 min3×/week
6"Simple 2EQ NIR20-30 J/cm²8-12 J/cm²3.5 - 5.5 min3×/week
12"Simple 1EQ NIR20-30 J/cm²8-12 J/cm²4.5 - 7 min3×/week
12"Simple 2EQ NIR20-30 J/cm²8-12 J/cm²4.5 - 6.5 min3×/week
18"Simple 1EQ NIR20-30 J/cm²8-12 J/cm²6.5 - 10 min3×/week
18"Simple 2EQ NIR20-30 J/cm²8-12 J/cm²5.5 - 8.5 min3×/week
24"Simple 1EQ NIR20-30 J/cm²8-12 J/cm²7.5 - 11.5 min3×/week
24"Simple 2EQ NIR20-30 J/cm²8-12 J/cm²6 - 9.5 min3×/week

Muscle Recovery (NIR-Only, Target: 15-30 J/cm² tissue dose)

DistanceDevice ModeSurface DoseTissue DoseTime RangeFrequency
12"Simple 1EQ NIR37-75 J/cm²15-30 J/cm²8.5 - 17 minPost-workout
12"Simple 2EQ NIR37-75 J/cm²15-30 J/cm²8 - 17 minPost-workout
18"Simple 1EQ NIR37-75 J/cm²15-30 J/cm²12 - 24 minPost-workout
18"Simple 2EQ NIR37-75 J/cm²15-30 J/cm²10.5 - 21 minPost-workout
24"Simple 1EQ NIR37-75 J/cm²15-30 J/cm²14 - 28.5 minPost-workout
24"Simple 2EQ NIR37-75 J/cm²15-30 J/cm²11.5 - 23 minPost-workout
36"Simple 1EQ NIR37-75 J/cm²15-30 J/cm²22 - 45 minPost-workout
36"Simple 2EQ NIR37-75 J/cm²15-30 J/cm²17 - 34 minPost-workout

HIGH-DOSE SPECIALTY PROTOCOLS

These conditions require higher energy delivery - monitor carefully

Osteoporosis/Bone Density (Target: 8-12 J/cm² tissue dose)

Recommended Wavelengths: 830-850nm for bone penetration

DistanceDevice ModeSurface DoseTissue DoseTime RangeProtocol
6"Simple 1EQ Full20-30 J/cm²8-12 J/cm²2.5 - 3.5 min3×/week × 6 weeks
6"Simple 2EQ Full20-30 J/cm²8-12 J/cm²2 - 3 min3×/week × 6 weeks
12"Simple 1EQ Full20-30 J/cm²8-12 J/cm²3 - 4 min3×/week × 6 weeks
12"Simple 2EQ Full20-30 J/cm²8-12 J/cm²2.5 - 4 min3×/week × 6 weeks
18"Simple 1EQ Full20-30 J/cm²8-12 J/cm²4 - 6 min3×/week × 6 weeks
18"Simple 2EQ Full20-30 J/cm²8-12 J/cm²3.5 - 5 min3×/week × 6 weeks
24"Simple 1EQ Full20-30 J/cm²8-12 J/cm²4.5 - 7 min3×/week × 6 weeks
24"Simple 2EQ Full20-30 J/cm²8-12 J/cm²3.5 - 5.5 min3×/week × 6 weeks

Cancer-Related Lymphedema (Target: 15-25 J/cm² tissue dose per site)

Recommended Wavelengths: 830nm optimal, multiple site treatment

DistanceDevice ModeSurface DoseTissue DoseTime per SiteProtocol
6"Simple 1EQ Full37-62 J/cm²15-25 J/cm²4 - 7 min2-3×/week
6"Simple 2EQ Full37-62 J/cm²15-25 J/cm²4 - 7 min2-3×/week
12"Simple 1EQ Full37-62 J/cm²15-25 J/cm²5 - 8.5 min2-3×/week
12"Simple 2EQ Full37-62 J/cm²15-25 J/cm²5 - 8 min2-3×/week
18"Simple 1EQ Full37-62 J/cm²15-25 J/cm²7.5 - 12.5 min2-3×/week
18"Simple 2EQ Full37-62 J/cm²15-25 J/cm²6.5 - 10.5 min2-3×/week
24"Simple 1EQ Full37-62 J/cm²15-25 J/cm²8.5 - 14 min2-3×/week
24"Simple 2EQ Full37-62 J/cm²15-25 J/cm²7 - 11.5 min2-3×/week

Radiation Dermatitis Prevention (Target: 3-6 J/cm² tissue dose)

Recommended Wavelengths: 660nm + 830nm combination

DistanceDevice ModeSurface DoseTissue DoseTime RangeProtocol
12"Simple 1EQ Full7.5-15 J/cm²3-6 J/cm²1 - 2 minBefore RT
12"Simple 2EQ Full7.5-15 J/cm²3-6 J/cm²1 - 2 minBefore RT
18"Simple 1EQ Full7.5-15 J/cm²3-6 J/cm²1.5 - 3 minBefore RT
18"Simple 2EQ Full7.5-15 J/cm²3-6 J/cm²1.5 - 2.5 minBefore RT
24"Simple 1EQ Full7.5-15 J/cm²3-6 J/cm²1.5 - 3.5 minBefore RT
24"Simple 2EQ Full7.5-15 J/cm²3-6 J/cm²1.5 - 3 minBefore RT
36"Simple 1EQ Full7.5-15 J/cm²3-6 J/cm²2.5 - 5.5 minBefore RT
36"Simple 2EQ Full7.5-15 J/cm²3-6 J/cm²2 - 4 minBefore RT

QUICK REFERENCE FORMULAS

Calculating Treatment Time:

Time (seconds) = Desired Surface Dose (J/cm²) ÷ Irradiance (mW/cm²) × 1000

Tissue Dose Calculation:

Actual Tissue Dose = Surface Dose × 0.4 (accounting for 60% loss)

Full Spectrum Irradiance Values:

  • Simple 1EQ: 145 mW/cm² (6"), 122 mW/cm² (12"), 73 mW/cm² (24"), 47 mW/cm² (36")
  • Simple 2EQ: 155 mW/cm² (6"), 125 mW/cm² (12"), 90 mW/cm² (24"), 61 mW/cm² (36")

NIR-Only Mode (60% of full power):

  • Simple 1EQ NIR: 87 mW/cm² (6"), 73 mW/cm² (12"), 44 mW/cm² (24"), 28 mW/cm² (36")
  • Simple 2EQ NIR: 93 mW/cm² (6"), 75 mW/cm² (12"), 54 mW/cm² (24"), 37 mW/cm² (36")

Estimated Irradiance at 18":

  • Simple 1EQ Full: ~85 mW/cm² (interpolated)
  • Simple 2EQ Full: ~100 mW/cm² (interpolated)
  • Simple 1EQ NIR: ~51 mW/cm² (60% of full)
  • Simple 2EQ NIR: ~60 mW/cm² (60% of full)

DISTANCE SELECTION GUIDE

When to Use Each Distance:

6-12 inches:

  • Targeted treatment of specific areas
  • Maximum intensity needed
  • Small coverage area acceptable
  • Deep tissue penetration priority

18-24 inches:

  • Balance of intensity and coverage
  • Most versatile distance range
  • Comfortable for seated/standing positions
  • Good for regional treatments (back, legs, torso)

36 inches:

  • Maximum coverage area (whole body)
  • Gentler treatment intensity
  • Ideal for sensitive individuals
  • Perfect for maintenance protocols
  • Best for sleep/relaxation sessions

Coverage Area Benefits by Distance:

Simple 1EQ Coverage Expansion:

  • 6": 126 sq inches (focused)
  • 12": 315 sq inches (2.5× larger)
  • 24": 587 sq inches (4.7× larger)
  • 36": 942 sq inches (7.5× larger)

Simple 2EQ Coverage Expansion:

  • 6": 324 sq inches (half body)
  • 12": 655 sq inches (2× larger)
  • 24": 1,068 sq inches (3.3× larger)
  • 36": 1,564 sq inches (4.8× larger - full body)

IMPORTANT SAFETY & USAGE GUIDELINES

Medical Disclaimer:

  • Not Medical Advice: This information is for educational purposes only
  • No Cure Claims: These protocols do not diagnose, treat, cure, or prevent any disease
  • Consult Professionals: Always consult qualified healthcare providers before starting
  • Individual Variation: Results vary significantly between individuals
  • Research Adaptation: Protocols are adapted from published studies, not clinical trials on SECOTRA devices

Safety Precautions:

  • Eye Protection: Never look directly at LEDs; use protective eyewear for face/head treatments
  • Skin Monitoring: Stop if skin becomes hot, red, or irritated
  • Medication Interactions: Some medications increase photosensitivity
  • Cancer Precaution: Avoid direct treatment over known tumors (controversial)
  • Pregnancy: Avoid abdominal treatments during pregnancy
  • Children: Require adjusted protocols and supervision

Starting Guidelines:

1. Begin Conservative: Start with shortest recommended times

2. Test Response: Try one small area first

3. Monitor Effects: Keep a treatment journal

4. Adjust Gradually: Increase time/frequency based on response

5. Be Consistent: Regular treatments work better than sporadic high doses

6. Stay Hydrated: Drink water before and after sessions

What to Expect:

  • Immediate Effects: Some conditions (acute pain) may respond immediately
  • Gradual Improvement: Most conditions require 2-4 weeks minimum
  • Temporary Reactions: Slight warmth, tingling normal during treatment
  • Healing Responses: Temporary increase in symptoms possible initially
  • Long-term Benefits: Consistency over 6-12 weeks yields best results

Contraindications:

  • Active skin infections
  • Open wounds (unless specifically treating)
  • Light-sensitive conditions
  • Recent steroid injections at treatment site
  • Suspicious skin lesions
  • Acute fever or illness

Treatment Tracking Suggestions:

  • Date and time of treatment
  • Distance and duration used
  • Body areas treated
  • Immediate sensations
  • Effects over following days
  • Any adverse reactions
  • Overall progress trends

WAVELENGTH SELECTION SUMMARY

By Tissue Depth:

  • Superficial (0-5mm): 630-670nm red light
  • Medium (5-10mm): 810nm near-infrared
  • Deep (10-30mm): 830-850nm near-infrared

By Condition Type:

  • Skin/Collagen: 630-670nm primary
  • Muscle/Athletic: 830-850nm primary
  • Joint/Bone: 830-850nm optimal
  • Brain/Nerve: 810nm optimal
  • Wound/Injury: 660nm + 830nm combo
  • Hair: 655nm ± 20nm specific

Full Spectrum vs NIR-Only:

Use Full Spectrum for:

  • General wellness
  • Skin conditions
  • Wound healing
  • Mood/sleep
  • First-time users

Use NIR-Only for:

  • Deep tissue focus
  • Joint/bone specific
  • Athletic recovery
  • Less skin sensitivity
  • Faster treatment times

RESEARCH BASIS DISCLAIMER

These protocols are based on adaptation of published peer-reviewed research studies including but not limited to:

  • Clinical trials on various photobiomodulation devices
  • Meta-analyses of light therapy effectiveness
  • Laboratory studies on optimal dosing parameters
  • FDA clearance documentation for specific applications

Important Notes:

  • Studies used various devices with different specifications
  • SECOTRA protocols are mathematical adaptations, not direct replications
  • Individual results may differ from study outcomes
  • This guide represents theoretical applications based on photophysics principles
  • No specific health claims are made for SECOTRA devices
  • Users assume all responsibility for their use of these devices

The 40% tissue penetration factor is an approximation based on:

  • Published research on light-tissue interactions
  • Skin reflection coefficients
  • Absorption and scattering losses
  • Average values across skin types

Individual penetration may vary based on:

  • Skin pigmentation
  • Tissue density
  • Hydration status
  • Treatment area
  • Age and health status

Version: 1.0

Last Updated: 2025

Copyright: Educational use permitted with attribution

Contact: Consult SECOTRA for device-specific questions

This guide is a living document and may be updated as new research emerges. Always refer to the latest version and consult healthcare providers for medical advice.